| MolName | 6-[(5Z)-5-[(2-morpholin-4-yl-4-oxopyrido[1,2-a]pyrimidin-3-yl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]hexanoic acid |
| MolecularFormula | C22H24N4O5S2 |
| Smiles | OC(CCCCCN(C(/C(/S1)=C/C2=C(N3CCOCC3)N=C(C=CC=C3)N3C2=O)=O)C1=S)=O |
| InChI | InChI=1S/C22H24N4O5S2/c27-18(28)7-2-1-4-9-26-21(30)16(33-22(26)32)14-15-19(24-10-12-31-13-11-24)23-17-6-3-5-8-25(17)20(15)29/h3,5-6,8,14H,1-2,4,7,9-13H2,(H,27,28) |
| InChIK | IQCIMQHGXYLYBP-UHFFFAOYSA-N |
| TotalMolweight | 488.588 |
| Molweight | 488.588 |
| MonoisotopicMass | 488.118811 |
| CLogP | 0.3889 |
| CLogS | -4.012 |
| H Acceptors | 9 |
| H Donors | 1 |
| TotalSurfaceArea | 357.64 |
| Relative PSA | 0.36313 |
| PolarSurfaceArea | 160.14 |
| Druglikeness | -4.6033 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | polar activated DB |
| Shape Index | 0.51515 |
| Fragments | 1 |
| Non HAtoms | 33 |
| NonCHAtoms | 11 |
| Electronegative Atoms | 11 |
| Rotatable Bond | 8 |
| Rings Closures | 4 |
| Small Rings | 4 |
| Sp3Atoms | 13 |
| Symmetricatoms | 2 |
| Amides | 2 |
| BasicNitrogens | 1 |
| AcidicOxygens | 1 |
| StereoCon |
Click to Load Molecule:
1 - 6-[(5Z)-5-[(2-morpholin-4-yl-4-oxopyrido[1,2-a]pyrimidin-3-yl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]hexanoic acid | 2 - 6-[(5Z)-5-[(2-morpholin-4-yl-4-oxopyrido[1,2-a]pyrimidin-3-yl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]hexanoic acid